Entero Healthcare shares gain 15% in 2 days after Prashant Jain’s 3P Investment picks stake in block deal

Shares of Entero Healthcare Solutions rallied as much as 6% to their day’s high of Rs 1,625 on the BSE on Tuesday after Prashant Jain-owned 3P Investment Managers acquired a 2.5% stake in the healthcare product distribution and supply chain platform through open market transactions on August 24. With today’s gain, the stock is up 15% in two sessions.

The 3P India Equity Fund 1M and 3P India Equity Fund 1 schemes, managed by 3P Investment, bought 10.88 lakh shares of Entero Healthcare for Rs 104.99 crore. The acquisition represents 2.5% of the company’s paid-up equity, stock exchange data showed.

The shares were purchased from Prasid Uno Family Trust at Rs 1,377.8 apiece.

Surbhi Singh, through Prasid Uno Family Trust, held a 10.45% stake, equivalent to 45.5 lakh shares, in Entero Healthcare as of the June 2026 shareholding pattern.

Entero Healthcare Q1 results

Faridabad-based Entero Healthcare Solutions reported a 38% year-on-year increase in consolidated revenue from operations to Rs 1,940.5 crore for the quarter ended June 30, 2026, compared with Rs 1,403.8 crore in the year-ago period.

Consolidated profit after tax (PAT) rose 72% year-on-year to Rs 52.1 crore, while profit before tax (PBT) increased 85% to Rs 67.1 crore. Profit attributable to owners of the company grew 37% year-on-year to Rs 38.2 crore.
The company’s operating performance also improved during the quarter, with EBITDA rising 94% year-on-year to Rs 97 crore. EBITDA margin expanded to 5% from 3.6% in the corresponding quarter last year.Entero said the MedTech market is large and growing, and has synergies with its pharmaceutical distribution business. It also sees significant consolidation potential in the segment, with distributors playing a high value-add role and having a higher margin profile than distributors in the pharmaceutical market.

The company’s existing MedTech business and acquisitions focus on the IVD and Cardiology/Orthopaedic devices segments, which it described as large and high-growth. The company has outlined these factors as the strategic rationale for its MedTech acquisitions.

Entero Healthcare share price performance

Entero Healthcare shares have gained more than 21% over the past month and around 32% so far this year. Over the past six months, the stock has climbed nearly 50%.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)